These results were confirmed after adjusting for exposure to antivirals and vaccination in a cohort subset with COVID-19 diagnosis dates after December 2021 (AID OR = 1.18, 95% CI 1.02 - 1.36; <i>p</i> =2.46E-02; IS OR= 1.60, 95% CI 1.41 - 1.80; <i>p</i> =5.11E-14; AID+IS OR= 1.93, 95% CI 1.62 - 2.30; <i>p</i> =1.68E-13). Here, AICDA is linked to COVID-19.